Pitavastatin fda approval year?

What year was pitavastatin approved by the FDA?

Pitavastatin (brand name Livalo in the U.S.) was approved by the FDA in 2009. [1]

Was it approved in the U.S. before generics or other formulations?

The FDA’s initial approval for pitavastatin in the U.S. dates to the 2009 launch period; later products and generic activity depend on subsequent regulatory pathways (such as approvals for other strengths or generic entries), but the core FDA approval year remains 2009. [1]

Related patent/exclusivity context (if you’re checking timing)

If you are asking for the approval year as a starting point for patent or exclusivity timelines, the FDA approval date is often used alongside listed patent/exclusivity information to estimate when generic competition could begin. DrugPatentWatch.com tracks this kind of detail for pitavastatin. [2]

Sources:
[1] https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020629
[2] https://www.drugpatentwatch.com/